4//SEC Filing
Bernard Gordon R 4
Accession 0001209191-19-059516
CIK 0001087294other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 5:15 PM ET
Size
4.8 KB
Accession
0001209191-19-059516
Insider Transaction Report
Form 4
Bernard Gordon R
Senior Vice President
Transactions
- Sale
Common Stock
2019-12-04$4.79/sh−1,000$4,790→ 0 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. This plan was established due to the policy change at Vanderbilt Medical Center requiring that senior executives divest holdings in biopharmaceutical companies.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001470015
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 5:15 PM ET
- Size
- 4.8 KB